Matthew Wade, CRNA | |
4315 Diplomacy Dr, Anchorage, AK 99508-5926 | |
(575) 302-7714 | |
Not Available |
Full Name | Matthew Wade |
---|---|
Gender | Male |
Speciality | Certified Registered Nurse Anesthetist (crna) |
Experience | 5 Years |
Location | 4315 Diplomacy Dr, Anchorage, Alaska |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1609416064 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
367500000X | Nurse Anesthetist, Certified Registered | 134693 (Alaska) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Carlsbad Medical Center | Carlsbad, NM | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Carlsbad Anesthesia Services Llc | 2365696960 | 10 |
News Archive
A.D.A.M., Inc., a leading provider of consumer health information, benefits technology solutions and award-winning education products, today announced the launch of www.adamimages.com.
A group of "professional couch potatoes," as one researcher described them, has proven that even moderate exercise - in this case walking at one's own pace for 40 minutes three times a week - can enhance the connectivity of important brain circuits, combat declines in brain function associated with aging and increase performance on cognitive tasks.
It is highly likely that children can transmit the new coronavirus, which causes COVID-19, but several factors suggest that children are unlikely to be the main drivers of the pandemic.
Infinity Pharmaceuticals, Inc. today announced new data from its ongoing Phase 1, open-label, dose-escalation trial of IPI-145, the company's potent, oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma, in patients with advanced hematologic malignancies.
› Verified 7 days ago
Entity Name | Carlsbad Anesthesia Services Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1043555204 PECOS PAC ID: 2365696960 Enrollment ID: O20130207000208 |
News Archive
A.D.A.M., Inc., a leading provider of consumer health information, benefits technology solutions and award-winning education products, today announced the launch of www.adamimages.com.
A group of "professional couch potatoes," as one researcher described them, has proven that even moderate exercise - in this case walking at one's own pace for 40 minutes three times a week - can enhance the connectivity of important brain circuits, combat declines in brain function associated with aging and increase performance on cognitive tasks.
It is highly likely that children can transmit the new coronavirus, which causes COVID-19, but several factors suggest that children are unlikely to be the main drivers of the pandemic.
Infinity Pharmaceuticals, Inc. today announced new data from its ongoing Phase 1, open-label, dose-escalation trial of IPI-145, the company's potent, oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma, in patients with advanced hematologic malignancies.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Matthew Wade, CRNA 8630 Ange St Unit A, Anchorage, AK 99515-1519 Ph: (575) 302-7714 | Matthew Wade, CRNA 4315 Diplomacy Dr, Anchorage, AK 99508-5926 Ph: (575) 302-7714 |
News Archive
A.D.A.M., Inc., a leading provider of consumer health information, benefits technology solutions and award-winning education products, today announced the launch of www.adamimages.com.
A group of "professional couch potatoes," as one researcher described them, has proven that even moderate exercise - in this case walking at one's own pace for 40 minutes three times a week - can enhance the connectivity of important brain circuits, combat declines in brain function associated with aging and increase performance on cognitive tasks.
It is highly likely that children can transmit the new coronavirus, which causes COVID-19, but several factors suggest that children are unlikely to be the main drivers of the pandemic.
Infinity Pharmaceuticals, Inc. today announced new data from its ongoing Phase 1, open-label, dose-escalation trial of IPI-145, the company's potent, oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma, in patients with advanced hematologic malignancies.
› Verified 7 days ago
Mrs. Jennifer Rae Ambrose, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 4100 Lake Otis Pkwy, Suite 222, Anchorage, AK 99508 Phone: 612-269-1918 | |
Waldron Upham, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 4100 Lake Otis Pkwy, Anchorage, AK 99508 Phone: 907-550-6110 | |
Tara Mccutcheon, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 2801 Debarr Rd, Anchorage, AK 99508 Phone: 801-915-1873 | |
Bucky M Frost, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 4315 Diplomacy Dr, Attn: Sherry Reedy, Anchorage, AK 99508 Phone: 907-729-3971 Fax: 907-729-1542 | |
Suzanne C Firth, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 5955 Zeamer Avenue, Anchorage, AK 99506 Phone: 907-580-1815 | |
Mrs. Alicia Marie Ferguson, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 611 Clipper Ship Ct, Anchorage, AK 99515 Phone: 907-306-1274 | |
Angela Malcom, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 4100 Lake Otis Pkwy, Anchorage, AK 99508 Phone: 907-550-6110 |